Literature DB >> 10680438

Bacterial flora accompanying Candida yeasts in clinical specimens.

C Hermann1, J Hermann, U Munzel, R Rüchel.   

Abstract

From 1986 to 1988, in the prefluconazole era, 67,765 clinical specimens from the Göttingen University Hospital were investigated for bacteria and fungi in our institution. Oral and throat swabs, respiratory secretions, gastric juices, faeces, urine, genital swabs, blood, wound secretions and skin swabs were analysed for yeast-like fungi, and opportunistic or pathogenic bacteria. A total of 5195 specimens (7.7%) yielded Candida spp. alone or in combination with bacteria (fungal (F-) group) and 62,570 specimens yielded bacteria only or remained sterile (non-fungal group, N-group). Elevated rates of accompanying bacteria were detected with Candida spp. colonizing blood, urine, and skin. Among the dominant bacterial isolates, the distribution of staphylococci and enterococci did not reflect a distinct association pattern. Among the enterobacterial isolates from patients in intensive care, colonization patterns of the throat, gastric juices, and faeces reflected the use of a selective decontamination of the digestive tract (SDD). A statistically significant association between Candida and enterobacteria of the genus Enterobacter which was unaffected by SDD, was observed throughout this study. Such an association pattern was also observed, to a lesser extent, with the related genera Klebsiella and Serratia, but not with Escherichia coli.

Entities:  

Mesh:

Year:  1999        PMID: 10680438     DOI: 10.1046/j.1439-0507.1999.00519.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  24 in total

Review 1.  Bacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologists.

Authors:  P Frey-Klett; P Burlinson; A Deveau; M Barret; M Tarkka; A Sarniguet
Journal:  Microbiol Mol Biol Rev       Date:  2011-12       Impact factor: 11.056

Review 2.  Medically important bacterial-fungal interactions.

Authors:  Anton Y Peleg; Deborah A Hogan; Eleftherios Mylonakis
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

Review 3.  Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Authors:  Sarah Höfs; Selene Mogavero; Bernhard Hube
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

4.  Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans.

Authors:  Carrie E Graham; Melissa R Cruz; Danielle A Garsin; Michael C Lorenz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

5.  Prevalence and spectrum of bacterial co-infection during fungal keratitis.

Authors:  J C Pate; D B Jones; K R Wilhelmus
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

6.  Pseudomonas aeruginosa-Candida albicans interactions: localization and fungal toxicity of a phenazine derivative.

Authors:  Jane Gibson; Arpana Sood; Deborah A Hogan
Journal:  Appl Environ Microbiol       Date:  2008-11-14       Impact factor: 4.792

7.  Candida albicans Airway Colonization Facilitates Subsequent Acinetobacter baumannii Pneumonia in a Rat Model.

Authors:  Xiaojiang Tan; Ruilan Chen; Song Zhu; Huijun Wang; Dongxing Yan; Xiangdong Zhang; Dimitrios Farmakiotis; Eleftherios Mylonakis
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

8.  Candida albicans and Enterococcus faecalis in the gut: synergy in commensalism?

Authors:  Danielle A Garsin; Michael C Lorenz
Journal:  Gut Microbes       Date:  2013-08-14

9.  Risky Business: Oropharyngeal Bacteria Linked to Risk for Invasive Fungal Infection.

Authors:  Anna Dongari-Bagtzoglou
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

10.  Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections.

Authors:  S-H Kim; Y K Yoon; M J Kim; J W Sohn
Journal:  Clin Microbiol Infect       Date:  2012-06-01       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.